The Europe IV hydration therapy market is estimated to be valued at US$ 244.1 million in 2022 and is expected to exhibit a CAGR of 7.2% during the forecast period (2022-2030).
Figure 1.Europe IV Hydration Therapy Market Share (%) in Terms of Value, by Component Type, 2022
The increasing strategies adopted by the key players such as establishments of clinics offering IV therapies is expected to drive growth of the Europe IV hydration therapy market over the forecast period
The increasing establishments of clinics offering IV therapies to increase the geographical presence of the companies is expected to drive the market growth over the forecast period. For instance, in 2018, REVIV, a company that offers IV therapies and vitamin injections, launched clinics at New York, London, and Hong Kong, in order to expand the healthcare services in various regions at global level.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients